Why is Maitreya Medica. falling/rising?

As of 29-Jul, Maitreya Medicare Ltd is currently priced at 247.95, reflecting an increase of 1.9 or 0.77%. Despite this uptick, the stock has underperformed its sector by 2.34% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a decline of 4.63%, and its performance over the last month shows a drop of 9.18%. Although it has generated a remarkable return of 96.09% over the past year, this is contrasted by a significant profit decline of 40%. The company's return on equity stands at 5.9, indicating an attractive valuation with a price-to-book value of 5.2. However, the company has not declared results in the last six months, raising concerns about its long-term fundamental strength.
In the broader market context, Maitreya Medicare Ltd's performance has been notably strong compared to the benchmark, as the BSE500 has experienced negative returns of 2.26% over the past year. However, the stock's recent performance has been lackluster, as indicated by its significant declines in profit after tax and operating profit margins. The rising investor participation, with a delivery volume increase of 150% against the 5-day average, suggests some interest in the stock despite its overall downward trend. The liquidity of the stock remains adequate for trading, but the weak fundamentals and lack of recent financial disclosures may contribute to investor caution.